Utilization of Mass Spectrometry for the Comprehensive Metabolite Profiling of Potential Medicinal plants: A Review Article

Mass spectrometry (MS), which provides unparalleled sensitivity, precision, and versatility for identifying and characterizing complex chemical compounds, has transformed metabolite profiling in medicinal plant research. This paper examines how MS can be used to profile primary and secondary metabolites that are essential to the pharmacological characteristics of medicinal plants, such as sugars, amino acids, alkaloids, flavonoids, terpenoids, and phenolics. Even in complex plant matrices, MS techniques like high-resolution mass spectrometry (HRMS) and tandem mass spectrometry (MS/MS) offer detailed structural elucidation of bioactive compounds. Our capacity to understand the metabolic complexity of medicinal plants has been greatly improved by the combination of targeted and untargeted metabolomics techniques. While untargeted metabolomics makes it easier to find new chemicals and identify metabolic pathways, targeted metabolomics concentrates on quantifying existing metabolites with particular therapeutic value. The resolution and dependability of metabolite detection are further improved by the application of sophisticated separation techniques, such as gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS). Through standardization and authentication procedures, MS contributes significantly to the quality, safety, and effectiveness of medicinal plant products beyond metabolite identification. MS-based metabolomics helps the creation of evidence-based plant-derived medications and verifies traditional medicinal claims by bridging the gap between traditional knowledge and contemporary analytical research. Additionally, MS applications support the sustainable use of plant resources by extending to ecological and conservation studies. The developments, difficulties, and potential paths in MS-based metabolomics for medicinal plants are highlighted in this study. It highlights how MS can be a key component of medication development and discovery, with a focus on phytochemical research, the identification of bioactive compounds, and therapeutic standardization. Researchers can increase the scientific basis of traditional medicine and promote innovation in the creation of plant-based therapies by utilizing MS technology to open up new avenues for natural product research.